mitomycin has been researched along with Vitreoretinopathy, Proliferative in 4 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the anatomic and visual outcomes of a new intraocular mitomycin c (MMC) application technique in the treatment of severe traumatic retinal detachment (RD) with advance proliferative vitreoretinopathy (PVR)." | 8.02 | Intraocular mitomycin C use in the treatment and prophylaxis of proliferative vitreoretinopathy in severe traumatic retinal detachments. ( Gürelik, G; Sül, S; Üçgül, AY, 2021) |
| "To assess the long-term anatomical and functional outcomes in addition to complications of a new surgical technique of localized intraocular application of mitomycin C (MMC) to prevent proliferative vitreoretinopathy (PVR) in eyes with open globe trauma." | 7.91 | Intraocular application of Mitomycin C to prevent proliferative vitreoretinopathy in perforating and severe intraocular foreign body injuries. ( Assi, A; Cherfan, G; Fakhoury, H; Helou, C; Khoueir, Z, 2019) |
| "To investigate the therapeutic potential of mitomycin C (MMC) in the management of proliferative vitreoretinopathy (PVR), antiproliferative effect of MMC on rabbit retinal pigment epithelial (RPE) cells, its intraocular toxicity, and its preventive effect on experimental PVR were investigated." | 7.69 | Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits. ( Chung, H; Yu, HG, 1997) |
| "To evaluate the anatomic and visual outcomes of a new intraocular mitomycin c (MMC) application technique in the treatment of severe traumatic retinal detachment (RD) with advance proliferative vitreoretinopathy (PVR)." | 4.02 | Intraocular mitomycin C use in the treatment and prophylaxis of proliferative vitreoretinopathy in severe traumatic retinal detachments. ( Gürelik, G; Sül, S; Üçgül, AY, 2021) |
| "To assess the long-term anatomical and functional outcomes in addition to complications of a new surgical technique of localized intraocular application of mitomycin C (MMC) to prevent proliferative vitreoretinopathy (PVR) in eyes with open globe trauma." | 3.91 | Intraocular application of Mitomycin C to prevent proliferative vitreoretinopathy in perforating and severe intraocular foreign body injuries. ( Assi, A; Cherfan, G; Fakhoury, H; Helou, C; Khoueir, Z, 2019) |
| "To investigate the therapeutic potential of mitomycin C (MMC) in the management of proliferative vitreoretinopathy (PVR), antiproliferative effect of MMC on rabbit retinal pigment epithelial (RPE) cells, its intraocular toxicity, and its preventive effect on experimental PVR were investigated." | 3.69 | Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits. ( Chung, H; Yu, HG, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gürelik, G | 1 |
| Sül, S | 1 |
| Üçgül, AY | 1 |
| Assi, A | 1 |
| Khoueir, Z | 1 |
| Helou, C | 1 |
| Fakhoury, H | 1 |
| Cherfan, G | 1 |
| Al-Harthi, E | 1 |
| Al-Shahwan, S | 1 |
| Al-Turkmani, S | 1 |
| Khan, AO | 1 |
| Yu, HG | 1 |
| Chung, H | 1 |
4 other studies available for mitomycin and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Intraocular mitomycin C use in the treatment and prophylaxis of proliferative vitreoretinopathy in severe traumatic retinal detachments.
Topics: Follow-Up Studies; Humans; Mitomycin; Retina; Retinal Detachment; Retrospective Studies; Silicone Oi | 2021 |
Intraocular application of Mitomycin C to prevent proliferative vitreoretinopathy in perforating and severe intraocular foreign body injuries.
Topics: Adolescent; Adult; Child; Choroid; Eye Foreign Bodies; Female; Humans; Injections, Intraocular; Intr | 2019 |
Retinal detachment and congenital glaucoma.
Topics: Combined Modality Therapy; Female; Humans; Hydrophthalmos; Intraocular Pressure; Male; Mitomycin; Po | 2007 |
Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits.
Topics: Animals; Cell Division; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; F | 1997 |